Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
about
Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents.Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen species-independent apoptosis.Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin.Extracellular vesicle-mimetic nanovesicles transport LncRNA-H19 as competing endogenous RNA for the treatment of diabetic wounds.Focus on Mesenchymal Stem Cell-Derived Exosomes: Opportunities and Challenges in Cell-Free Therapy.Liposomes for the delivery of streptokinase.Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.
P2860
Q37651420-CA15D2E0-0044-4FB7-8537-48893AAADD61Q42335714-8FB081EA-F7F7-4B5A-A814-4E6D5AEB7A6DQ46252995-8C333819-2A08-4F9E-8469-DDCEC99FD379Q47162683-3CC4C0C5-6F14-422E-B7EB-31ED6199A838Q47732044-92F1946E-BDFB-4D72-9CDB-A8D1CDB1B5CCQ48095278-B46CEB49-5447-4535-ABDB-1095515D973AQ49853329-0BAEBAAF-3609-4F20-9F9A-8694640D855CQ50422486-871E6A08-369D-4AF8-94D5-159962E4DFF6Q52646034-6C2A564B-80CB-4D17-954C-FBFA3C2098DEQ52647638-C6F14353-3A95-4C03-9E66-C365E9163113Q52647650-8D21ECB9-7E6A-48C0-95E2-2DDB77C84B43Q55076479-4F1FA3B0-2C41-4F89-87CD-A71D600E233BQ55369803-A0AEF93D-68A9-4203-BFBA-520D55A03C4C
P2860
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
@nl
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
@ast
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
@en
type
label
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
@nl
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
@ast
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
@en
prefLabel
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
@nl
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
@ast
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
@en
P2860
P921
P3181
P356
P1433
P1476
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
@en
P2093
Kevin Hwang
P2860
P304
P3181
P356
10.7150/THNO.15464
P407
P50
P577
2016-06-15T00:00:00Z